Home › Funds › DENALI ADVISORS LLC › AMPH

DENALI ADVISORS LLC position in AMPH

AMPHASTAR PHARMACEUTICALS IN · Health Care

DENALI ADVISORS LLC reported holding 386,865 shares of AMPH (AMPHASTAR PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$10.0M, representing 1.00% of its reported portfolio and ranking #10 among its reported holdings. DENALI ADVISORS LLC has disclosed AMPH holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)386.87K sh
Reported value held$9.98M
Portfolio Weight1.00%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DENALI ADVISORS LLC's AMPH position evolved

DENALI ADVISORS LLC first disclosed a stake in AMPH in Q3 2025 at 135,000 shares (US$3.6M). The position peaked in Q3 2026 at 386,865 shares, worth US$10.0M. Across 5 filings, DENALI ADVISORS LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 386,865 shares valued at US$10.0M — an increase of 10,900 shares quarter over quarter.. Notable position changes include a 57% increase in Q4 2025 (shares fell 27% over the following quarter), a 26% increase in Q1 2026 (shares rose 3% over the following quarter), a 41% increase in Q2 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 135.00K $3.60M New
Q4 2025 211.76K $5.67M Add
Q1 2026 266.46K $5.22M Add
Q2 2026 375.96K $7.59M Add
Q3 2026 386.87K $9.98M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMPH and 13F data

AMPH (AMPHASTAR PHARMACEUTICALS IN) is a Health Care company. 18 other funds we track also report a position in AMPH — the largest reported positions include Context Capital Management, LLC (US$84.6M), DeepCurrents Investment Group LLC (US$41.0M), OAKTREE CAPITAL MANAGEMENT LP (US$37.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMPH

All AMPH fund holders →

FAQ

How long has DENALI ADVISORS LLC held AMPH?

DENALI ADVISORS LLC has disclosed AMPH holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is DENALI ADVISORS LLC's current position in AMPH?

As of Q3 2026, DENALI ADVISORS LLC holds 386.87K shares of AMPH (AMPHASTAR PHARMACEUTICALS IN), valued at $9.98M, representing 1.00% of its reported portfolio and ranking #10.

Has DENALI ADVISORS LLC been buying or selling AMPH?

In the latest 13F filing (Q3 2026), DENALI ADVISORS LLC increased its position in AMPH. The position peaked in Q3 2026 at 386.87K shares.

Which other funds hold AMPH?

Other major institutional holders of AMPH include Context Capital Management, LLC, DeepCurrents Investment Group LLC, OAKTREE CAPITAL MANAGEMENT LP, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.